Recomienda este artículo a tus amigos:
Resistance to Anti Cancer Therapeutics Targeting Receptor Tyrosine Kinases and D 1st ed. 2018 edition
Resistance to Anti Cancer Therapeutics Targeting Receptor Tyrosine Kinases and D
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.
240 pages, 22 Illustrations, color; XX, 240 p. 22 illus. in color.
| Medios de comunicación | Libros Book |
| Publicado | 10 de abril de 2018 |
| ISBN13 | 9783319679303 |
| Editores | Springer International Publishing AG |
| Páginas | 242 |
| Dimensiones | 150 × 220 × 20 mm · 565 g |
| Lengua | Alemán |
| Editor | Elkabets, Moshe |
| Editor | Yarden, Yosef |